FDA Clears Stereotaxis Guidewire for Peripheral Chronic Total Occlusions

Conventional catheters are designed to be operated mechanically from their proximal or back end. They are necessarily stiff to allow for steering through a series of cables. In contrast, Stereotaxis’ proprietary catheters are controlled directly at their working end by a magnetic field and are extremely...

NexMed Gets Nailed, Stock Price Derails

On Tuesday, NexMed announced that it would shelve its previously filed NDA for an onychomycosis treatment (NM100060) following disappointing Phase III clinical results. Onychomycosis, or toenail fungus, affects six to eight percent of the adult U.S. population. Because the infection is embedded within the...

[Video] Interview with Dr. Irwin Goldstein, Director of Sexual Medicine at Alvarado Hospital

San Diego Sexual Medicine at Alvarado Hospital, led by physician Irwin Goldstein, attempts to improve sexual health through the prevention, diagnosis, treatment, and rehabilitation of conditions or diseases that involve sexual function. Current areas of research and exploration include: Bicycle Riding:...

[Video] POM Wonderful: Seriously Profitable Science-Backed Marketing

POM Wonderful was founded by Stewart and Lynda Rae Resnick, who purchased a 100-acre pomegranate orchard in 1987. The company launched its namesake juice in 2002. From 2003 to 2006, annual sales climbed from $12 million to $91 million. The company is now the largest grower and distributor of pomegranates...

Kensey Nash Q4: A Well Oiled Machine

Revenues at Kensey Nash grew to a record $22 million in the company’s latest quarter, a 29% increase over the same period last year. Net sales grew to $15.0 million, a 42% increase from the $10.5 million reported in Q4 2007. Orthopedic sales increased 39% to $8.4 million, primarily due to a strong...

Celleration Raises $30 Million to Accelerate Sales & Marketing

Ultrasound wound healing device developer Celleration has successfully completed a Series D financing, raising $30 million. Heron Capital, Venture Investors and Clarian Health led the round. Celleration, founded in 1999, will use the proceeds to expand and accelerate its sales and marketing efforts. The...

[Video Profile] Interview with Joseph Galli, President & CEO of Haemacure

Haemacure is developing human biological adhesives, hemostats and therapeutic proteins. The company’s research and development efforts are driven by a proprietary plasma protein extraction process. Haemacure’s product development activities focus on surgical hemostats, wound management, drug...

Thermage Considers Third Party Acquisition at Huge Premium

Thermage has received an unsolicited takeover bid from an as-yet-unnamed third party calling for the acquisition of all outstanding shares at $5.50 a piece. That bid, to be paid in cash or a combination of cash and stock (it appears to be a public company) represents an 82% premium over yesterday’s closing...